Regulatory T cells in skin are uniquely poised to suppress profibrotic immune responses
- 13 September 2019
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 4 (39)
- https://doi.org/10.1126/sciimmunol.aaw2910
Abstract
Skin T regs depend on GATA3 to attenuate immune cell–stimulated cutaneous fibrosis. See the related Focus by Bal and Stadhouders .Keywords
Funding Information
- NIH Office of the Director (K08-AR062064)
- Scleroderma Research Foundation
This publication has 57 references indexed in Scilit:
- Transcription factor Foxp3 and its protein partners form a complex regulatory networkNature Immunology, 2012
- Mechanisms of fibrosis: therapeutic translation for fibrotic diseaseNature Medicine, 2012
- Extrathymically generated regulatory T cells control mucosal TH2 inflammationNature, 2012
- Genome-wide Analyses of Transcription Factor GATA3-Mediated Gene Regulation in Distinct T Cell TypesImmunity, 2011
- Interleukin-10 Signaling in Regulatory T Cells Is Required for Suppression of Th17 Cell-Mediated InflammationImmunity, 2011
- The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammationNature Immunology, 2009
- Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control TH2 responsesNature, 2009
- Unique functions of the type II interleukin 4 receptor identified in mice lacking the interleukin 13 receptor α1 chainNature Immunology, 2007
- Regulatory T cell development in the absence of functional Foxp3Nature Immunology, 2007
- PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetesNature Genetics, 2003